Stroke risk and NSAIDs: a systematic review of observational studies
- 3 October 2011
- journal article
- review article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 20 (12), 1225-1236
- https://doi.org/10.1002/pds.2227
Abstract
Aims To perform a quantitative systematic review of observational studies on the risk of stroke associated with the use of individual NSAIDs. Methods and results Searches were conducted using the Medline database within PubMed (1990–2008). Observational cohort or case–control studies were eligible if reported on the risk of cardiovascular events associated with individual NSAIDs versus the nonuse of NSAIDs. We found 3193 articles, in which 75 were eligible for review and abstraction. Of the 75 articles, 6 reported relative risk (RR) of stroke. Data were abstracted into a database using a standardized entry form. Two authors assessed study quality, and discrepancies were resolved by consensus. The pooled RR of all subtypes of incident stroke was increased with the current use of rofecoxib (RR = 1.64, 95% CI = 1.15–2.33) and diclofenac (RR = 1.27, 95% CI = 1.08–1.48). The pooled estimates for naproxen, ibuprofen, and celecoxib were close to unity. The risk of ischemic stroke was also increased with rofecoxib (RR = 1.82, 95% CI = 1.09–3.04) and diclofenac (RR = 1.20, 95% CI = 0.99–1.45). Data were inadequate to estimate the pooled RR by dose and duration, for other individual NSAIDs or nonischemic stroke subtypes. Conclusion This meta‐analysis supports an increased risk of ischemic stroke with the current use of rofecoxib and diclofenac. Additional studies are required to evaluate most individual NSAIDS, the effect of dose and duration, and the subtypes of stroke. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Use of disease risk scores in pharmacoepidemiologic studiesStatistical Methods in Medical Research, 2009
- Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trialsAnnals Of The Rheumatic Diseases, 2007
- Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health dataPharmacoepidemiology and Drug Safety, 2007
- Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)PLoS Clinical Trials, 2006
- Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs and the Risk of Ischemic StrokeStroke, 2006
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Cardiovascular Events Associated with Long-Term Use of Celecoxib, Rofecoxib and Meloxicam in TaiwanDrug Safety, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialThe New England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionThe New England Journal of Medicine, 2005
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986